Abstract:The pulmonary epithelial glycocalyx is rich in glycosaminoglycans such as hyaluronan and heparan sulfate. Despite their presence, the precise role of these glycosaminoglycans in bacterial lung infections remains elusive. To address this, we intranasally inoculated mice with in the presence or absence of enzymes targeting pulmonary hyaluronan and heparan sulfate, followed by characterization of subsequent disease pathology, pulmonary inflammation, and lung barrier dysfunction. Enzymatic degradation of hyaluronan and heparan sulfate exacerbated pneumonia in mice, as evidenced by increased disease scores and alveolar neutrophil recruitment. However, targeting epithelial hyaluronan further exacerbated systemic disease, indicated by elevated splenic bacterial load and plasma levels of pro-inflammatory cytokines. In contrast, enzymatic cleavage of heparan sulfate resulted in increased bronchoalveolar bacterial burden, lung damage and pulmonary inflammation in mice infected with . Accordingly, heparinase-treated mice also exhibited disrupted lung barrier integrity as evidenced by higher alveolar edema scores and vascular protein leakage into the airways. This finding was corroborated in a human alveolus-on-a-chip platform, confirming that heparinase treatment also disrupts the human lung barrier. Notably, enzymatic pre-treatment with either hyaluronidase or heparinase also rendered human epithelial cells more sensitive to pneumococcal-induced barrier disruption, as determined by transepithelial electrical resistance measurements, consistent with our findings in murine pneumonia. Taken together, these findings demonstrate the importance of intact hyaluronan and heparan sulfate in controlling pneumococcal virulence, pulmonary inflammation, and epithelial barrier function.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the roles of heparan sulfate and hyaluronan in the pulmonary glycocalyx during the infection process of Streptococcus pneumoniae. Specifically, the study aims to answer the following questions: 1. **Do heparan sulfate and hyaluronan in the glycocalyx play a protective role in bacterial pneumonia?** 2. **Does the enzymatic degradation of these glycosaminoglycans affect the severity of Streptococcus pneumoniae infection?** 3. **Does the enzymatic degradation of these glycosaminoglycans change the pulmonary inflammatory response, barrier function, and bacterial load?** ### Research Background The pulmonary glycocalyx is an extracellular structure composed of glycoproteins and proteoglycans, attached to the plasma membrane of almost all cells, including alveolar epithelial cells. These glycosaminoglycans (such as heparan sulfate and hyaluronan) may play important roles in maintaining pulmonary barrier function, regulating the inflammatory response, etc. However, their specific functions in bacterial pneumonia are not fully understood. ### Research Methods To explore these questions, the researchers used a mouse model and introduced Streptococcus pneumoniae (S. pneumoniae) into the mouse lungs by intranasal administration, while adding hyaluronidase targeting hyaluronan or heparinase targeting heparan sulfate. Then, they evaluated the following changes: - **Disease Progression**: Monitor clinical parameters such as body temperature, body weight, and behavior scores. - **Pathological Changes**: Assess the degree of lung damage and inflammation through histological analysis. - **Bacterial Load**: Measure the number of bacteria in bronchoalveolar lavage fluid (BAL) and lung tissue. - **Immune Response**: Detect leukocyte infiltration and the levels of inflammatory factors. - **Barrier Function**: Evaluate lung permeability and vascular leakage. ### Main Findings The study shows that the enzymatic degradation of hyaluronan and heparan sulfate can significantly exacerbate the symptoms of Streptococcus pneumoniae infection: - **Increased Disease Severity**: Manifested as more severe body temperature drop, weight loss, and worsened behavior scores. - **Increased Bacterial Load**: Especially in the heparinase - treated group, the number of bacteria in BAL and lung tissue increased significantly. - **Enhanced Inflammatory Response**: More neutrophil infiltration and higher levels of inflammatory factors (such as IL - 6, TNF - α, etc.) were observed. - **Impaired Barrier Function**: Heparinase treatment led to increased lung permeability, with obvious pulmonary edema and vascular leakage. ### Conclusion In summary, this study reveals the importance of intact heparan sulfate and hyaluronan for controlling the virulence of Streptococcus pneumoniae, reducing pulmonary inflammation, and maintaining epithelial barrier function. These findings provide a new perspective for further understanding the role of glycocalyx in pulmonary infections and a potential direction for developing new treatment strategies. \[ \text{Formula Example:} \] \[ \text{Definition of Hyaluronidase Unit:} \quad 1 \, \text{unit} = \frac{0.75 \, \mu g \, \text{HA}}{\text{min}} \] \[ \text{Definition of Heparinase Unit:} \quad 1 \, \text{Sigma unit} = \frac{0.1 \, \mu mol \, \text{unsaturated uronic acid}}{\text{hour}} \]

Enzymatic modulation of the pulmonary glycocalyx alters susceptibility to

Enzymatic Modulation of the Pulmonary Glycocalyx Enhances Susceptibility to Streptococcus pneumoniae

Deacetylation of sialic acid by esterases potentiates pneumococcal neuraminidase activity for mucin utilization, colonization and virulence

Microenvironmental acidification by pneumococcal sugar consumption fosters barrier disruption and immune suppression in the human alveolus

Endothelial ENaC-α Restrains Oxidative Stress in Lung Capillaries in Murine Pneumococcal Pneumonia-associated Acute Lung Injury

Epithelial Heparan Sulfate Contributes to Alveolar Barrier Function and is Shed During Lung Injury.

Sulfated motifs in heparan sulfate inhibit Streptococcus pneumoniae adhesion onto fibronectin and attenuate corneal infection

Pneumococcal Neuraminidases Increase Platelet Killing by Pneumolysin

Epithelial microinvasion and immunity elicited by disease-attenuated pneumococcal biosynthesis gene mutants

Modulation of Human Bronchial Epithelial Cells by Pneumococcal Choline Binding Protein A

Blocking HXA -mediated neutrophil elastase release during lung infection limits pulmonary epithelial barrier disruption and bacteremia

Blocking HXA3-mediated neutrophil elastase release during S. pneumoniae lung infection limits pulmonary epithelial barrier disruption and bacteremia

Weakened airway epithelial junctions and enhanced neutrophil elastase release contribute to age-dependent bacteremia risk following pneumococcal pneumonia

The unremarkable alveolar epithelial glycocalyx: a thorium dioxide-based electron microscopic comparison after heparinase or pneumolysin treatment

Modulation of the Inflammatory Response Tostreptococcus Pneumoniaein a Model of Acute Lung Tissue Infection

Lung epithelium and myeloid cells cooperate to clear acute pneumococcal infection

Pseudomonas aeruginosa pyocyanin modulates mucin glycosylation with sialyl-Lewis(x) to increase binding to airway epithelial cells

K. pneumoniae and M. smegmatis infect epithelial cells via different strategies

Bacterial surface lipoproteins mediate epithelial microinvasion by Streptococcus pneumoniae

Neuraminidase Reprograms Lung Tissue and Potentiates Lipopolysaccharide-Induced Acute Lung Injury in Mice.